Small particle liposome aerosols for delivery of anti-cancer drugs
AssigneeResearch Development Foundation
InventorsJ. Vernon Knight, Brian Gilbert, J. Clifford Waldrep, Nadezhda Koshkina
Life of this patent
Estimating the term…
Loading patent…
AssigneeResearch Development Foundation
InventorsJ. Vernon Knight, Brian Gilbert, J. Clifford Waldrep, Nadezhda Koshkina
Estimating the term…
The small particle liposome or lipid complex aerosol compounds and methods of treatment of the present invention involve lipid- or water soluble anti-cancer drugs incorporated into liposomes or other lipid complexes. The liposomes and complexes are administered in aqueous dispersions from a jet nebulizer to the respiratory tract of an individual. Various anti-cancer drugs may be used, including 20-S-Camptothecin, 9-Nitro-camptothecin, 9-Amino-camptothecin, 10, 11-methylenedioxy-camptothecin and taxol or its derivatives. Administration of these drugs by inhalation provides faster and more efficient absorption of the anticancer drug than does intramuscular administration or oral administration.
A method for treating cancer, comprising the step of delivering, via small particle aerosol, aqueous dispersions of anti-cancer drugs in liposomes to the respiratory tract of an individual in need of such treatment, wherein said anti-cancer drug is selected from the group consisting of taxol, taxol-A, mitotane, methotrexate, mercaptopurine, lomustine, interferon, 5-fluorouracil and etopside and wherein a final concentration of said anticancer drug in said liposomes is no greater than 5.0 mg/ml.
Dependencies are inferred from the claim text.